PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low‐level oxidative stress and direct PGE2 neurotoxicity
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Oxidative stress and increased cyclooxygenase‐2 (COX‐2) activity are both implicated in the loss of dopaminergic neurons from the substantia nigra (SN) in idiopathic Parkinson's disease (PD). Prostaglandin E 2 (PGE 2) is one of the key products of COX‐2 activity and PGE 2 production is increased in PD. However, little is known about its role in the selective death of dopaminergic neurons. Previously, we showed that oxidative stress evoked by low concentrations of 6‐hydroxydopamine (6‐OHDA) was selective for dopaminergic neurons in culture and fully dependent on COX‐2 activity. We postulated that this loss was mediated by PGE 2 acting through its receptors, EP1, EP2, EP3, and EP4. Using double‐label immunohistochemistry for specific EP receptors and tyrosine hydroxylase (TH), we identified EP1 and EP2 receptors on dopaminergic neurons in rat SN. EP2 receptors were also found in non‐dopaminergic neurons of this nucleus, as were EP3 receptors, whereas the EP4 receptor was absent. PGE 2, 16‐phenyl tetranor PGE 2 (a stable synthetic analogue), and 17‐phenyl trinor PGE 2 (an EP1 receptor–selective agonist) were significantly toxic to dopaminergic cells at nanomolar concentrations; EP2‐ and EP3‐selective agonists were not. We challenged dopaminergic neurons in embryonic rat mesencephalic primary neuronal cultures and tested whether these receptors mediate selective 6‐OHDA toxicity. The nonselective EP1–3 receptor antagonist AH‐6809 and two selective EP1 antagonists, SC‐19220 and SC‐51089, completely prevented the 40%–50% loss of dopaminergic neurons caused by exposure to 5 μM 6‐OHDA. Together, these results strongly implicate PGE 2 activation of EP1 receptors as a mediator of selective toxicity in this model of dopaminergic cell loss. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011 · cited 1×
“PGE2, a key product of COX-2, plays a number of diverse roles in both normal and disease states and acts by binding to four versions of G protein– coupled ‘‘endogenous pyrogen,’’ or EP (EP1, EP2, EP3, and EP4) receptors (Breyer et al., 2001; Bos et al., 2004; Hata and Breyer, 2004).”
BackgroundInflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · cited 2×
“COX-2 expression is strongly up-regulated, as is PGE2 synthesis, in Parkinson’s disease (PD) and the MPTP animal model of PD and is positioned to contribute to the death of dopaminergic neurons (Mattammal et al., 1995; Knott et al., 2000; Teismann et al., 2003).”
BackgroundInduction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain
Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300187 · Cited by 155 · cited 1×
“Oxidative stress can increase inflammatory activity and, conversely, inflammation is known to cause oxidative stress (Madrigal et al., 2003; Teismann et al., 2003; Liao et al., 2007).”
Background
Cited by
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727
Emerging roles of PGE2 receptors in models of neurological disease
Andreasson, K. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.003 · Cited by 219
Ki, Y.-W., Park, J. H., Lee, J. E., Shin, I. C., & Koh, H. C. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.003 · Cited by 203
Zeng, K.-W., Zhang, T., Fu, H., Liu, G.-X., & Wang, X.-M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.030 · Cited by 116
Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, H. M., & Batiha, G. E.-S. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01192-2 · Cited by 47
Metadata
- Authors
- Carrasco, E., Casper, D., & Werner, P.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-09-14
- Volume
- 85
- Issue
- 14
- Pages
- 3109-3117
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2127747069
- Cited by
- 84
- References
- 5
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.